Guide

Ozempic Cost Without Insurance in 2026: Every Route, Priced

Ozempic lists at roughly $998 a month. Nothing you do without insurance gets you Ozempic itself much below that. The routes that actually cut the cost switch you to a dif

What Ozempic actually costs at the counter

Ozempic's list price sits at roughly $998 a month for a 28-day supply. That is the number you meet with no coverage, no savings card and no substitution.

Two things are worth being blunt about before the tables start. First, Ozempic is licensed for type 2 diabetes, not for weight management — Wegovy is the same molecule licensed for weight. If weight is the reason you are searching, the diabetes brand is usually the wrong product to be pricing at all. Second, manufacturer savings cards are a copay-reduction layer. Without commercial insurance paying a share there is no copay to reduce, so the card does close to nothing.

Every route, priced

Only the captured rows were read on the provider's own page by us, with a date. Everything else is a claim we have recorded but not confirmed at source. See our evidence grades.

Why the savings card usually fails

Novo Nordisk's Ozempic savings card can bring a covered patient to about $25 a month. The eligibility condition that most people fail is not the diagnosis, it is the plan: the card reduces a copay, and without commercial insurance covering the drug there is no copay.

Federal law also bars manufacturer copay cards on any drug paid by Medicare Part D, Medicare Advantage, Medicaid, TRICARE or the VA. There is no workaround for that. Eligible Medicare enrollees have a separate route at roughly $50 a month through the GLP-1 Bridge, which began 1 July 2026.

The question to ask before any of this

If you have a type 2 diabetes diagnosis, coverage for Ozempic is far more common than coverage for a weight-management GLP-1, because most plans cover diabetes drugs and a large share still exclude obesity medications entirely. A five-minute call to the number on your insurance card — is Ozempic on my formulary, and at what tier? — decides which half of this page applies to you.

What the cheap routes cost you in evidence

Every efficacy figure attached to semaglutide comes from a trial of an FDA-approved product. STEP-1 reported roughly 14.9% mean weight loss over 68 weeks. SELECT reported a 20% reduction in major adverse cardiovascular events in people with overweight or obesity and established cardiovascular disease.

None of that was collected on a compounded preparation. The molecule is the same; the product in your hand was never in a trial. That does not make it ineffective, and we do not claim it does. It means the evidence being shown to you was gathered on something else, and at $145 against $149 the trade is no longer cost against evidence — it is a preference about route.

One question specific to compounded semaglutide

Semaglutide sodium and semaglutide acetate are not the same active ingredient as the semaglutide base in the approved products, and the FDA has said they are not appropriate for compounding. Ask any compounded provider for the exact salt form and concentration, in writing. This has no tirzepatide equivalent.

The six tests, applied to everyone

Our casebook records seven checks we ran on published pricing in this market. Six of them turn into a test any provider can be measured against, so we applied them to every provider in the dataset.

How to work out your own number

1. Call your plan. Ozempic covered for diabetes is often near $25 with the card.
2. Price the approved pill. $149, its own trial programme, no injection.
3. Add every membership before comparing anything. A $79 fee on a $99 programme is an 80% uplift.
4. Ask what the maintenance dose costs, not the starting dose, and get it in writing.
5. Ask the salt form if the product is compounded.

Our semaglutide pricing page holds every figure with its capture date, and the comparison matrix records which providers answer these questions at all.

Questions readers actually ask

Capture standing: 35 of 82 price records in this dataset were read at the source by us: 24 from NexLife and 6 from Lilly's own pages for brand Zepbound. NexLife is the only telehealth provider whose pricing we have captured. Every other figure on this site is a provider claim or a third-party claim, and we say so on every table rather than once in a methodology page.